Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this observational study is to compare patients with pulmonary atresia with intact ventricular septum (PA-IVS) with univentricular circulation to patients with the same heart defect but that has a biventricular circulation in regards to mortality, quality of life, comorbidity, cardiac function, and work capacity. The main questions the study aims to answer are:
• Do mortality, quality of life, comorbidity, cardiac function, and work capacity differ between patients with PA-IVS who have univentricular and biventricular circulation?
Participants will be asked to answer a Quality of Life questionnaire. The investigators will also inquire with a sample size of the research subjects (based on place of residence) about their participation in a series of examinations (ergo-spirometry to assess work capacity, transthoracic echocardiogram, magnetic resonance of the heart and blood sampling to assess cardiac function and cardiac health).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Biventricular circulation | Research subjects with PA-IVS who have biventricular circulation | ||
| Univentricular circulation | Research subjects with PA-IVS who have univentricular circulation |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Difference in comorbidity between the two groups | Difference in myocardial infarction, heart failure, arrhythmia, stroke, malignancy, autoimmune diseases, infections, atopy, certain liver diseases, and protein-losing enteropathy between the two groups | September 2024 |
| Measure | Description | Time Frame |
|---|---|---|
| Difference in quality of life between the two groups | A validated quality of life questionnaire (PROMIS Scale v1.2-Global Health) will be sent to all the research subjects and the answers will be compared between the two groups. The questionnaire consists of a ten-item patient reported measure of physical, mental and social health. Each statement is answered on a scale from 1-5, higher scores mean better outcome. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Individuals born with pulmonary atresia with intact ventricular septum who are younger than 15 years old at the start of the study.
Not provided
Not provided
Not provided
The study population consists of all individuals with PA-IVS who have been registered in Swedcon (a national register for patients with congenital heart defects) or in the National Patient Register and Cause of Death Register since 1980 and meet other inclusion criteria, including age.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| stina manhem, MD | Contact | +46735080342 | stina.manhem@vgregion.se |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pediatric Heart Center, Queen Silvia's Children's hospital | Recruiting | Gothenburg | 416 85 | Sweden |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Jun 19, 2023 | Jun 19, 2023 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| C562832 | Pulmonary Atresia with Intact Ventricular Septum |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| September 2024 |
| Difference in physical capacity between the two groups | Ergospirometry, outcome variables: exercise test (exercise capacity measured in watt and over time, counted in minutes), oxygen saturation (measured in percent), blood pressure (measured in millimetre of mercury) | September 2024 |
| Difference in cardiac capacity between the two groups | Transthoracic echocardiogram | September 2024 |
| Difference in general health, linked to cardiac health, between the two groups | The following blood tests will be analysed: N-terminal pro-brain natriuretic peptide (a marker for heart failure), Alanine aminotransferase (a liver enzyme), Aspartate aminotransferase (a liver enzyme), Creatinine (a waste product from muscle metabolism, used to assess kidney function), Sodium (an electrolyte), Potassium (an electrolyte), Hemoglobin (a protein in red blood cells that carries oxygen), White blood cell count (Leukocyte count), Platelet count (Thrombocyte count), Albumin: A protein produced by the liver that helps maintain fluid balance in the body, TREC (T-receptor excision circles): A marker used to assess immune function, specifically the production of new T cells, Expanded lymphocyte typing (a comprehensive examination of lymphocyte subtypes) | September 2024 |
| Difference in mortality between the groups | September 2024 |